Trial Profile
VRC 008: A phase I clinical trial of a prime-boost HIV-1 vaccination schedule: Multiclade DNA vaccine, VRC-HIVDNA016-00-VP, followed by multiclade adenoviral vector vaccine, VRC-HIVADV014-00-VP, in uninfected adult volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jan 2017
Price :
$35
*
At a glance
- Drugs VRC-HIVADV014-00-VP (Primary) ; VRC-HIVDNA016-00-VP (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 02 Dec 2005 New trial record.